search
Back to results

Commercial Single Step (Vitrolife -G-TL™) Media Compared With Cornell Media

Primary Purpose

Infertility

Status
Terminated
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
embryo culture in buffered media
Sponsored by
Weill Medical College of Cornell University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Infertility

Eligibility Criteria

18 Years - 40 Years (Adult)FemaleAccepts Healthy Volunteers

Inclusion Criteria:

  • 40 years of age or younger (maternal) 65 years of age or younger (paternal)
  • Patient must have 10 or greater than 10 mature oocytes, ICSI only
  • Fresh or frozen (including donor) sperm can be used. Fresh oocytes only (including donor)
  • Frozen embryos from this study can be included in the outcome portion of this study.
  • Single or double Blastocyst transfer only

Exclusion Criteria:

  • Patients having PGS (Pre-implantation Genetic Screening)
  • 3 or more previous failed cycles
  • Sperm obtained by testicular biopsy
  • Previous enrollment in the study
  • Non blastocyst transfer
  • Co-culture patients
  • Outcome data portion exclusion only:

Multi-source media transfers if researchers are unable to determine the media source after transfer.

Sites / Locations

  • Center fo Reproductive Medicine

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm Type

Active Comparator

Active Comparator

Experimental

Experimental

Arm Label

CRM sequential media (C1/C2)

CRM single step media (C3)

Vitrolife media G1/2 Sequential

Vitrolife G-TL Time Lapse media Single Step

Arm Description

CRM sequential media, formulated according to the stages of embryo development, is used to culture the embryos from oocyte fertilization to blastocyst stage.

CRM single step media is used to culture the embryos from oocyte fertilization to blastocyst stage.

Vitrolife sequential media, formulated according to the stages of embryo development, is used to culture the embryos from oocyte fertilization to blastocyst stage.

G-TL Time Lapse Single step (time lapse) media is formulated for continuous culture from oocyte fertilization to blastocyst stage.

Outcomes

Primary Outcome Measures

Embryo development
Comparison of embryo development using standard assessments of morphokenetics of embryo development

Secondary Outcome Measures

Embryo transfer rate
Percentage of embryo transferred in each arm.
Clinical pregnancy rates
Percentage of embryos transferred that implant into the uterus by evidence of a fetal sac by ultrasound

Full Information

First Posted
July 28, 2015
Last Updated
April 27, 2017
Sponsor
Weill Medical College of Cornell University
Collaborators
Vitrolife
search

1. Study Identification

Unique Protocol Identification Number
NCT02527642
Brief Title
Commercial Single Step (Vitrolife -G-TL™) Media Compared With Cornell Media
Official Title
Commercial Single Step (Vitrolife -G-TL™) Media Compared With Cornell Media: A Randomized Controlled Trial by Time-Lapse System- Single Step vs Sequential Media
Study Type
Interventional

2. Study Status

Record Verification Date
April 2017
Overall Recruitment Status
Terminated
Why Stopped
Lack of recruitment
Study Start Date
July 2015 (undefined)
Primary Completion Date
October 17, 2016 (Actual)
Study Completion Date
April 2017 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Weill Medical College of Cornell University
Collaborators
Vitrolife

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
This is a randomized, controlled, single-center study in otherwise healthy infertile female subjects undergoing in vitro fertilization (IVF). The subjects recruited for this study will be among those patients who have been diagnosed with infertility and are planning to undergo IVF at the centers where this study is being performed. The patients will have undergone the usual informed consent procedure at the center.
Detailed Description
Subjects will undergo ovarian stimulation, oocyte retrieval, IVF, and Intra Cytoplasmic Sperm Injection (ICSI) procedure following the center's usual procedures. The cohort of injected oocytes from each patient will be randomly divided between the one step and sequential medias: CRM (Cornell- Center for Reproductive Medicine) media (C1/C2 or C3) vs G-TL Time Lapse media or G-1/G-2 media. Single step or sequential media are both buffered mediums for culture from oocyte fertilization to blastocyst stage. Sequential media is formulated according to the stages of embryo development and embryos are re-cultured in medias according to their stage of development. Single step (time lapse) media is formulated for continuous culture from D0 to Day 5/6. Mature oocytes will be randomized via a non-bias computer program into two to four of the study groups: G-TL commercial single step (Vitrolife), Vitrolife's sequential media, Cornell's single step , and Cornell's sequential media. Oocytes will be divided randomly among the various media dependent upon the number of mature oocytes. I.e.: 10 oocytes injected = 2 media groups; 15 oocytes injected = up to 3 media groups; 20 oocytes injected = up to 4 media groups. "Best grade" embryos will be transferred regardless of media source. If embryos are transferred from multi-source media and if researchers are unable to determine the media source after transfer, the subject will not be included in the outcome data portion of the study- e.g pregnancy outcome. The Time-Lapse monitoring system will be used as standard clinical practice to observe development and document timing of embryo cleavages and morphology dynamics. Endpoints will be Day 3 and Day 5/6 embryo development, implantation and pregnancy rate. The study is approximately 2 months, the estimated time it takes a physician to perform one IVF-ART IVF- Assisted Reproductive Technology) treatment cycle. If embryos are frozen, the patient may be in the study until the time they choose to thaw the embryos or up to 1 year if they become pregnant.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Infertility

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
13 (Actual)

8. Arms, Groups, and Interventions

Arm Title
CRM sequential media (C1/C2)
Arm Type
Active Comparator
Arm Description
CRM sequential media, formulated according to the stages of embryo development, is used to culture the embryos from oocyte fertilization to blastocyst stage.
Arm Title
CRM single step media (C3)
Arm Type
Active Comparator
Arm Description
CRM single step media is used to culture the embryos from oocyte fertilization to blastocyst stage.
Arm Title
Vitrolife media G1/2 Sequential
Arm Type
Experimental
Arm Description
Vitrolife sequential media, formulated according to the stages of embryo development, is used to culture the embryos from oocyte fertilization to blastocyst stage.
Arm Title
Vitrolife G-TL Time Lapse media Single Step
Arm Type
Experimental
Arm Description
G-TL Time Lapse Single step (time lapse) media is formulated for continuous culture from oocyte fertilization to blastocyst stage.
Intervention Type
Other
Intervention Name(s)
embryo culture in buffered media
Other Intervention Name(s)
Embryo media- CRM media vs Vitrolife
Intervention Description
compare media that supports human embryo development in the laboratory (in vitro) using Time-Lapse system.
Primary Outcome Measure Information:
Title
Embryo development
Description
Comparison of embryo development using standard assessments of morphokenetics of embryo development
Time Frame
1 year
Secondary Outcome Measure Information:
Title
Embryo transfer rate
Description
Percentage of embryo transferred in each arm.
Time Frame
1 year
Title
Clinical pregnancy rates
Description
Percentage of embryos transferred that implant into the uterus by evidence of a fetal sac by ultrasound
Time Frame
within 3 months of embryo transfer
Other Pre-specified Outcome Measures:
Title
Number of participants pregnant after Frozen Embryo Transfer
Description
Pregnancy rate from frozen embryo transfer in each arm.
Time Frame
2 years

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
40 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: 40 years of age or younger (maternal) 65 years of age or younger (paternal) Patient must have 10 or greater than 10 mature oocytes, ICSI only Fresh or frozen (including donor) sperm can be used. Fresh oocytes only (including donor) Frozen embryos from this study can be included in the outcome portion of this study. Single or double Blastocyst transfer only Exclusion Criteria: Patients having PGS (Pre-implantation Genetic Screening) 3 or more previous failed cycles Sperm obtained by testicular biopsy Previous enrollment in the study Non blastocyst transfer Co-culture patients Outcome data portion exclusion only: Multi-source media transfers if researchers are unable to determine the media source after transfer.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Nikica Zaninovic, PhD
Organizational Affiliation
Weill Medical College of Cornell University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Center fo Reproductive Medicine
City
New York
State/Province
New York
ZIP/Postal Code
10021
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Commercial Single Step (Vitrolife -G-TL™) Media Compared With Cornell Media

We'll reach out to this number within 24 hrs